"N Engl J Med"[journal] 检索结果

721. Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.

作者: Jennifer R Brown.;John F Seymour.;Wojciech Jurczak.;Andrew Aw.;Malgorzata Wach.;Arpad Illes.;Alessandra Tedeschi.;Carolyn Owen.;Alan Skarbnik.;Daniel Lysak.;Ki-Seong Eom.;Martin Šimkovič.;Miguel Arturo Pavlovsky.;Arnon Philip Kater.;Barbara Eichhorst.;Kara Miller.;Veerendra Munugalavadla.;Ting Yu.;Marianne de Borja.;Paolo Ghia.; .; .
来源: N Engl J Med. 2025年392卷8期748-762页

Whether fixed-duration acalabrutinib-venetoclax (with or without obinutuzumab) would result in better progression-free survival than chemoimmunotherapy in patients with untreated chronic lymphocytic leukemia (CLL) is unknown.

722. Risdiplam for Prenatal Therapy of Spinal Muscular Atrophy.

作者: Richard S Finkel.;Samuel H Hughes.;JulieAnn Parker.;Matthew Civitello.;Alfonso Lavado.;Heather C Mefford.;Lutz Mueller.;Heidemarie Kletzl.; .
来源: N Engl J Med. 2025年392卷11期1138-1140页

723. Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer. Reply.

作者: Aditya Bardia.;Maria Schwaederle.;Giuseppe Curigliano.
来源: N Engl J Med. 2025年392卷8期830-831页

724. Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer.

作者: Fabio Conforti.;Chiara Oriecuia.;Laura Pala.
来源: N Engl J Med. 2025年392卷8期830页

725. Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer.

作者: Riqing Huang.;Meiting Chen.;Yanxia Shi.
来源: N Engl J Med. 2025年392卷8期829-830页

726. Trastuzumab Deruxtecan in Low or Ultralow HER2 Metastatic Breast Cancer.

作者: Antonio C Wolff.;Lisa M McShane.;Kimberly H Allison.
来源: N Engl J Med. 2025年392卷8期829页

727. Biomarkers and 30-Year Cardiovascular Outcomes in Women. Reply.

作者: Paul M Ridker.;Julie E Buring.
来源: N Engl J Med. 2025年392卷8期828页

728. Biomarkers and 30-Year Cardiovascular Outcomes in Women.

作者: Chenlin Pei.;Weishe Zhang.;Jingrui Huang.
来源: N Engl J Med. 2025年392卷8期828页

729. Biomarkers and 30-Year Cardiovascular Outcomes in Women.

作者: Chun Gui.;Yuan Huang.
来源: N Engl J Med. 2025年392卷8期827-828页

730. Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease. Reply.

作者: Min Soo Cho.;Gi-Byoung Nam.;Duk-Woo Park.
来源: N Engl J Med. 2025年392卷8期826-827页

731. Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.

作者: Yutaka Shimazu.
来源: N Engl J Med. 2025年392卷8期826页

732. Edoxaban for Atrial Fibrillation and Stable Coronary Artery Disease.

作者: Thomas Gremmel.
来源: N Engl J Med. 2025年392卷8期826页

733. The Duration of Immunotherapy for Mismatch Repair-Deficient Cancers.

作者: Benoit Rousseau.;James R White.;Andrea Cercek.;Luis A Diaz.
来源: N Engl J Med. 2025年392卷8期824-826页

734. Another Win for SGLT2 Inhibitors in Chronic Kidney Disease.

作者: David E Leaf.;Nisha Bansal.
来源: N Engl J Med. 2025年392卷8期822-823页

735. A Hitchhiker's Guide to Antibody-Mediated Rejection.

作者: Parmjeet Randhawa.
来源: N Engl J Med. 2025年392卷8期820-821页

736. Catheter Ablation for Ventricular Tachycardia - The Case for Earlier Intervention.

作者: Timothy M Markman.
来源: N Engl J Med. 2025年392卷8期818-819页

737. Case 6-2025: A 62-Year-Old Man with Abdominal Pain.

作者: Gabrielle K Bromberg.;Robert G Rasmussen.;Kenneth E Sherman.;Sanjeeva P Kalva.;Katayoon Goodarzi.;Jonathan N Glickman.
来源: N Engl J Med. 2025年392卷8期807-816页

738. Cutaneous Larva Migrans.

作者: Amanda Truong.;Stephanie Martin.
来源: N Engl J Med. 2025年392卷8期e22页

739. Tubal Ectopic Pregnancy.

作者: Courtney A Schreiber.;Sarita Sonalkar.
来源: N Engl J Med. 2025年392卷8期798-805页

740. Low-Dose Yellow Fever Vaccine in Adults in Africa.

作者: Derick Kimathi.;Aitana Juan-Giner.;Ndeye S Bob.;Benedict Orindi.;Maria L Namulwana.;Antoine Diatta.;Stanley Cheruiyot.;Gamou Fall.;Moussa Dia.;Mainga M Hamaluba.;Dan Nyehangane.;Henry K Karanja.;John N Gitonga.;Daisy Mugo.;Donwilliams O Omuoyo.;Mwatasa Hussein.;Elizaphan Oloo.;Naomi Kamau.;Jackline Wafula.;Josephine Bendera.;Namanya Silvester.;James Mwavita.;Musiimenta Joshua.;Jane Mwendwa.;Collins Agababyona.;Caroline Ngetsa.;Nalusaji Aisha.;Felix Moki.;Titus Buluku.;Marianne Munene.;Juliet Mwanga-Amumpaire.;Julius Lutwama.;John Kayiwa.;Eunice Kamaara.;Alan D Barrett.;Pontiano Kaleebu.;Philip Bejon.;Amadou A Sall.;Rebecca F Grais.;George M Warimwe.; .
来源: N Engl J Med. 2025年392卷8期788-797页

Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain unknown.

结果排序

文献格式

出版时间

出版类型

出版语言